Funding for this research was provided by:
CSL Behring
Article History
Received: 17 May 2018
Accepted: 11 November 2018
First Online: 3 December 2018
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: M Hoffman received research funding from CSL Behring, Novo Nordisk and Boehringer Ingelheim and served as consultant for CSL Behring and Novo Nordisk. JH Levy serves on scientific advisory boards for CSL Behring, Boehringer Ingelheim, Octapharma, Instrumentation Labs, and Merck. JNĀ Goldstein received research funding from Pfizer and Portola, and served as a consultant to CSL Behring and Octapharma.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.